Literature DB >> 21705382

Characterization of unique signature sequences in the divergent maternal protein Bcl2l10.

Yannis Guillemin1, Aurélie Cornut-Thibaut, Germain Gillet, François Penin, Abdel Aouacheria.   

Abstract

Insertions or deletions (indels) of amino acids residues have been recognized as an important source of genetic and structural divergence between paralogous Bcl-2 family members. However, these signature sequences have not so far been extensively investigated amongst orthologous Bcl-2 family proteins. Bcl2l10 is an antiapoptotic member of the Bcl-2 family that has evolved rapidly throughout the vertebrate lineage and which shows conserved abundant expression in eggs and oocytes. In this paper, we have unraveled two major sites of divergence between human Bcl2l10 and its vertebrate homologs. The first one provides length variation at the N-terminus (before the BH4 domain) and the second one is located between the predicted α5-α6 pore-forming helices, providing an unprecedented case in the superfamily of helix-bundled pore-forming proteins. These two particular indels were studied phylogenetically and through biochemical and cell biological techniques, including truncation and site-directed mutagenesis. While deletion of the N-terminal extension had no significant functional impact in HeLa cells, our results suggest that the human Bcl2l10 protein evolved a calcium-binding motif in its α5-α6 interhelical region by acquiring critical negatively charged residues. Considering the reliance of female eggs on calcium-dependent proteins and calcium-regulated processes and the exceptional longevity of oocytes in the primate lineage, we propose that this microstructural variation may be an adaptive feature associated with high maternal expression of this Bcl-2 family member.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705382     DOI: 10.1093/molbev/msr152

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  4 in total

1.  The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist.

Authors:  G J P Rautureau; M Yabal; H Yang; D C S Huang; M Kvansakul; M G Hinds
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

2.  IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact.

Authors:  Benjamin Bonneau; Hideaki Ando; Katsuhiro Kawaai; Matsumi Hirose; Hiromi Takahashi-Iwanaga; Katsuhiko Mikoshiba
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

3.  Evolution of Bcl-2 homology motifs: homology versus homoplasy.

Authors:  Abdel Aouacheria; Valentine Rech de Laval; Christophe Combet; J Marie Hardwick
Journal:  Trends Cell Biol       Date:  2012-11-27       Impact factor: 20.808

4.  Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B.

Authors:  B van de Kooij; R W Rooswinkel; F Kok; M Herrebout; E de Vries; M Paauwe; G M C Janssen; P A van Veelen; J Borst
Journal:  Oncogene       Date:  2013-04-08       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.